These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17193687)

  • 21. Quantitative gadopentetate-enhanced MRI of breast tumors: testing of different analytic methods.
    Helbich TH; Roberts TP; Gossmann A; Wendland MF; Shames DM; Adachi M; Yang S; Huber S; Daldrup H; Brasch RC
    Magn Reson Med; 2000 Dec; 44(6):915-24. PubMed ID: 11108629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixture model approach to tumor classification based on pharmacokinetic measures of tumor permeability.
    Spilker ME; Seng KY; Yao AA; Daldrup-Link HE; Shames DM; Brasch RC; Vicini P
    J Magn Reson Imaging; 2005 Oct; 22(4):549-58. PubMed ID: 16161077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: initial phase II multicenter trial.
    Daldrup-Link HE; Rydland J; Helbich TH; Bjørnerud A; Turetschek K; Kvistad KA; Kaindl E; Link TM; Staudacher K; Shames D; Brasch RC; Haraldseth O; Rummeny EJ
    Radiology; 2003 Dec; 229(3):885-92. PubMed ID: 14576446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrinsic susceptibility MR imaging of chemically induced rat mammary tumors: relationship to histologic assessment of hypoxia and fibrosis.
    McPhail LD; Robinson SP
    Radiology; 2010 Jan; 254(1):110-8. PubMed ID: 20032145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gadofluorine M-enhanced magnetic resonance imaging of inflammatory bowel disease: quantitative analysis and histologic correlation in a rat model.
    Frericks BB; Kühl AA; Loddenkemper C; Stroux A; Valdeig S; Hotz B; Misselwitz B; Hoffmann JC; Wacker FK
    Invest Radiol; 2011 Aug; 46(8):478-85. PubMed ID: 21512398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gadolinium-free extracellular MR contrast agent for tumor imaging.
    Nofiele JT; Haedicke IE; Zhu Yle K; Zhang XA; Cheng HL
    J Magn Reson Imaging; 2015 Feb; 41(2):397-403. PubMed ID: 24399613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations.
    Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC
    Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [MR imaging of lymph nodes using Gadofluorine M: feasibility in a swine model at 1.5 and 3T].
    Spuentrup E; Ruhl K; Weigl S; Misselwitz B; Wardeh D; Buhl A; Botnar RM; Katoh M; Wiethoff AJ; Günther RW
    Rofo; 2010 Aug; 182(8):698-705. PubMed ID: 20419610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with Gadofluorine M.
    Meding J; Urich M; Licha K; Reinhardt M; Misselwitz B; Fayad ZA; Weinmann HJ
    Contrast Media Mol Imaging; 2007; 2(3):120-9. PubMed ID: 17557276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
    Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
    Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of hyperventilation for improving the visualization of glial tumors of the brain in magnetic resonance tomography using the contrast substance Gd-DTPA].
    Pronin IN; Kornienko VN; Petriaĭkin AV; Golanov AV
    Zh Vopr Neirokhir Im N N Burdenko; 1995; (3):10-3. PubMed ID: 7483947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted contrast agent helps to monitor advanced plaque during progression: a magnetic resonance imaging study in rabbits.
    Zheng J; Ochoa E; Misselwitz B; Yang D; El Naqa I; Woodard PK; Abendschein D
    Invest Radiol; 2008 Jan; 43(1):49-55. PubMed ID: 18097277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gadofluorine m uptake in stem cells as a new magnetic resonance imaging tracking method: an in vitro and in vivo study.
    Giesel FL; Stroick M; Griebe M; Tröster H; von der Lieth CW; Requardt M; Rius M; Essig M; Kauczor HU; Hennerici MG; Fatar M
    Invest Radiol; 2006 Dec; 41(12):868-73. PubMed ID: 17099425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gadofluorine M-enhanced magnetic resonance nerve imaging: comparison between acute inflammatory and chronic degenerative demyelination in rats.
    Wessig C; Jestaedt L; Sereda MW; Bendszus M; Stoll G
    Exp Neurol; 2008 Mar; 210(1):137-43. PubMed ID: 18061168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlative dynamic contrast MRI and microscopic assessments of tumor vascularity in RIP-Tag2 transgenic mice.
    Sennino B; Raatschen HJ; Wendland MF; Fu Y; You WK; Shames DM; McDonald DM; Brasch RC
    Magn Reson Med; 2009 Sep; 62(3):616-25. PubMed ID: 19526501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study.
    Bendszus M; Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Stoll G
    Brain; 2008 Sep; 131(Pt 9):2341-52. PubMed ID: 18669504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation.
    Daldrup-Link HE; Okuhata Y; Wolfe A; Srivastav S; Øie S; Ferrara N; Cohen RL; Shames DM; Brasch RC
    Microcirculation; 2004; 11(5):387-96. PubMed ID: 15280064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugate of arabinogalactan as a potential liver-targeting magnetic resonance imaging contrast agent.
    Xiao Y; Xue R; You T; Li X; Pei F; Wang X; Lei H
    Carbohydr Res; 2014 Aug; 395():9-14. PubMed ID: 24995911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of phyllodes breast tumors from fibroadenomas on MRI.
    Wurdinger S; Herzog AB; Fischer DR; Marx C; Raabe G; Schneider A; Kaiser WA
    AJR Am J Roentgenol; 2005 Nov; 185(5):1317-21. PubMed ID: 16247156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.